Filing Details

Accession Number:
0001110803-13-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-31 21:26:06
Reporting Period:
2013-01-29
Filing Date:
2013-01-31
Accepted Time:
2013-01-31 21:26:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1110803 Illumina Inc ILMN Laboratory Analytical Instruments (3826) 330804655
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1364711 Christian Cabou 5200 Illumina Way
San Diego CA 92122
Sr Vp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-29 5,333 $0.00 45,856 No 4 A Direct
Common Stock Acquisiton 2013-01-30 30,000 $28.45 75,856 No 4 M Direct
Common Stock Disposition 2013-01-30 30,000 $50.62 45,856 No 4 S Direct
Common Stock Acquisiton 2013-01-30 10,500 $32.49 56,356 No 4 M Direct
Common Stock Disposition 2013-01-30 10,500 $50.84 45,856 No 4 S Direct
Common Stock Acquisiton 2013-01-30 15,000 $20.04 60,856 No 4 M Direct
Common Stock Disposition 2013-01-30 15,000 $50.94 45,856 No 4 S Direct
Common Stock Acquisiton 2013-01-31 35,000 $13.70 80,856 No 4 M Direct
Common Stock Disposition 2013-01-31 35,000 $50.54 45,856 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-01-31 35,000 $0.00 35,000 $13.70
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-01-30 15,000 $0.00 15,000 $20.04
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-01-30 30,000 $0.00 30,000 $28.45
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-01-30 10,500 $0.00 10,500 $32.49
Common Stock Performance Shares Acquisiton 2013-01-29 24,000 $0.00 24,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-05-30 2016-05-30 No 4 M Direct
0 2007-02-25 2017-01-25 No 4 M Direct
0 2009-02-28 2019-01-28 No 4 M Direct
0 2008-02-29 2018-01-29 No 4 M Direct
24,000 2016-01-03 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect by Spouse
Footnotes
  1. Grant of restricted stock units that vest as follows: 25% of the Shares subject to the Award become vested on each of the first four anniversaries of grant date, subject to Awardee's continuing to be a Service Provider on such dates.
  2. The sale was made pursuant to a 10b5-1 plan.
  3. Weighted average sale price representing 30,000 shares sold ranging from $50.37 to $50.80 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  4. Weighted average sale price representing 10,500 shares sold ranging from $50.80 to $50.88 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  5. Weighted average sale price representing 15,000 shares sold ranging from $50.88 to $51.01 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  6. Weighted average sale price representing 35,000 shares sold ranging from $50.07 to $50.99 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  7. Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 3, 2016. The number of shares issued will range from 50% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending January 3, 2016 relative to pre-defined objectives.